- Report
- March 2024
- 397 Pages
Global
From €7673EUR$7,950USD£6,582GBP
- Report
- June 2020
- 113 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- January 2021
- 145 Pages
China, Global
From €3000EUR$3,330USD£2,663GBP
- Report
- April 2024
- 50 Pages
Global
From €2558EUR$2,650USD£2,194GBP
- Report
- April 2024
- 50 Pages
Global
From €2558EUR$2,650USD£2,194GBP
Chlorpromazine is a drug used to treat schizophrenia, a mental disorder characterized by delusions, hallucinations, and disorganized thinking. It is a first-generation antipsychotic, meaning it is one of the oldest drugs used to treat schizophrenia. Chlorpromazine works by blocking dopamine receptors in the brain, which helps reduce the symptoms of schizophrenia. It is usually taken orally, but can also be administered intravenously or intramuscularly.
Chlorpromazine is one of the most commonly prescribed drugs for schizophrenia, and is widely available in generic form. It is generally well-tolerated, but can cause side effects such as drowsiness, dry mouth, and blurred vision. It is also associated with an increased risk of metabolic syndrome, which can lead to weight gain and diabetes.
The chlorpromazine market is highly competitive, with many generic and branded versions of the drug available. Major pharmaceutical companies such as Pfizer, Novartis, and Johnson & Johnson are all involved in the market. Other companies such as Mylan, Teva, and Sandoz also produce generic versions of the drug. Show Less Read more